Abstract
Uveitis is a heterogeneous group of infectious and noninfectious intraocular inflammatory diseases. Management of both subsets of uveitis is frequently challenging. Since 2000, advances in microbial diagnostics and introduction of biologic drugs, combined with the potential for electronic communication to facilitate research on diseases with low incidence, have provided uveitis specialists with unprecedented opportunities for clinical trials to establish evidence-based management algorithms. Hampering this effort, however, was lack of a common system for describing uveitis, including diagnosis, severity, and outcome.
Original language | English |
---|---|
Pages (from-to) | 1084-1085 |
Number of pages | 2 |
Journal | Ophthalmology |
Volume | 124 |
Issue number | 7 |
Early online date | 31 Mar 2017 |
DOIs | |
Publication status | Published - Jul 2017 |
Keywords
- Uveitis
- Nomenclature
- Inflammatory diseases